Endometriosis is defined as the presence of endometrial tissue outside the uterine cavity. It 15 affects approximately 5-10% of women of reproductive age. Endometriosis is associated with 16 dysmenorrhea, dyspareunia and, often, severe pelvic pain. In addition to pain, women with 17 endometriosis often experience infertility. Defining the molecular etiology of endometriosis 18 is a significant challenge for improving the quality of women's lives. Unfortunately, the 19 pathophysiology of endometriosis is not well understood. Here, we summarize the potential 20 causative factors of endometriosis in the following three categories: 1) dysregulation of 21 immune cells in the peritoneal fluid and endometriotic lesions; 2) alteration of apoptotic 22 signaling in retrograde menstrual tissue and cytotoxic T cells involved in endometriosis 23 progression; and 3) dysregulation of oxidative stress. Determining the molecular etiology of 24 these dysregulated cellular signaling pathways should provide crucial clues for understanding 25 initiation and progression of endometriosis. Moreover, improved understanding should 26 suggest new molecular therapeutic targets that could improve the specificity of endometriosis 27 treatments and reduce the side effects associated with current approaches. 28 29 30 31
not in samples from healthy control women (Bellelis, et al. 2013; de Barros, et al. 2017; Slabe, 262 et al. 2013) . To initiate and establish endometriosis, retrograde menstrual tissues in the 263 peritoneal region must escape the host immune surveillance system. To achieve this, the large 264 numbers of Treg cells in the T cell population and endometriotic lesions decrease the 265 recruitment of immune cells to prevent the recognition and targeting of retrograde menstrual 266 tissues, thus allowing their survival and implantation into ectopic sites.
267
Th17 cells and IL23 levels in endometriosis: In addition to Th2 cytokines, the levels of IL23 268 and the Th17 cytokine IL17 are highly elevated in the peritoneal fluid of women with 269 minimal or mild endometriosis (Andreoli, et al. 2011) . Th17 cells are involved in the 270 pathogenesis of several autoimmune diseases, and endometriosis is associated with a higher 271 risk (20-60%) of autoimmune disease, such as multiple sclerosis, systemic lupus 272 erythematosus, and Sjögren syndrome (Nielsen, et al. 2011; Ouyang, et al. 2008a) . In vitro 273 stimulation of endometrial epithelial carcinoma cells, Ishikawa cells, and HUVECs with 274 IL17A revealed that IL17A treatment significantly increased angiogenic (VEGF and IL8), 275 pro-inflammatory (IL6 and IL1β), and chemotactic cytokine levels (G-CSF, CXCL12, 276 CXCL1, and CX3CL1) (Ahn, et al. 2015) . The levels of IL23 were significantly higher in the 277 peritoneal fluid of women with endometriosis compared to normal controls (Andreoli et al.
278
2011). Activated naïve T cells produce IL23, which then increases the levels of IL10 and 279 IL17, both of which are required for endometriosis progression (Vanden Eijnden, et al. 2005) .
280
Dysregulation of IL23 is also involved in several endometriosis-associated endometrial 281 dysfunctions, such as infertility (Andreoli et al. 2011; Frazer, et al. 2013) .
282

Altered T cell activation and autoimmune properties of endometriosis: Endometriosis is not
283 itself an autoimmune disease; however, women with endometriosis may have been reported to have a higher risk of developing several autoimmune diseases, such as systemic lupus 285 erythematosus, Sjögren's syndrome, multiple sclerosis, and rheumatoid arthritis (Haga, et al. 286 2005; Harris, et al. 2016) . This is somewhat controversial however, as another study reported 287 no correlation between them (Nielsen et al. 2011) . In many autoimmune diseases, altered 288 activation of CD4 + T cells plays a critical role in activating B cells to stimulate the production 289 of autoantibodies (Palmer and Weaver 2010). Consistent with autoimmune disease, the 290 elevated levels of autoantibodies against the endometrium and ovary are highly elevated in 291 endometriosis patient (Mathur, et al. 1982) . Therefore, altered activation of CD4 + T cells, as peritoneal macrophages express inducible nitric oxide synthase (iNOS) and COX2 through interferon regulatory factors (IRFs), NF-κB and nuclear factor (Nrf)2 through activation of STAT, p38, ERK and JNK signaling cascades. Activated macrophages then release cytokines (including IL1, IL6, IL8, IL10, IL12, IL13, and TNFα), growth factors, and angiogenic factors (VEGF and platelet-derived growth factor [PDGF]). The secreted TNFα, IL1β and IL6 bind their membrane receptors in endometriotic lesions. The cytokine/cytokine receptor complex then activates PI3K, MKK, JNK, p38 and IKK pathways to induce the expression of inflammation and invasion mediators, such as StAR, COX2 and MMP9, through NF-κB and AP1 transcription factors to stimulate local estradiol formation, PEG2 formation and tissue remodeling and NCOA-1 isoform generation, which enhances the growth of endometriotic lesions. The estradiol/ESR2/NCOA-1 complex interacts with the cytoplasmic inflammasome to increase IL1β levels to induce monocyte differentiation into macrophages (Schenk, et al. 2014) . Therefore, cytokine crosstalk between endometriotic cells and macrophages is the main driver for the initiation, maintenance, and progression of endometriosis.
254x190mm (96 x 96 DPI) Figure 2 . Dysregulation of apoptotic signaling in endometriosis. The decreased apoptosis of endometriotic cells and increased apoptosis of immune cells leads to immune privilege. TNFα, elevated by retrograde menstruation, binds to tumor necrosis factor receptor (TNFR) to induce caspase 8-and caspase 9-mediated apoptosis in retrograde menstrual tissues. In endometriosis patients, however, elevated NCOA-1 isoform/ESR2 complex binds to ASK1 (apoptosis complex I), caspase 8 (apoptosis complex II) and caspase 9 (apoptosome) and suppresses extrinsic apoptosis signaling in retrograde menstrual tissues. The elevation of PGE2 in endometriosis patients increases the ratio of BCL2/BAX in mitochondria to inhibit intrinsic apoptosis signaling. The endometriotic lesions also exhibit elevated levels of FasL, which binds to Fas in cytotoxic T cells, causing cell death in cytotoxic T cells. This represents a critical defense mechanism of endometriotic lesions against destruction by cytotoxic T cells during retrograde menstruation.
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